Trial #1: People aged 18 to 70 who have hepatitis C virus and HIV will take BI 201335 (an experimental HCV protease inhibitor) with peg-interferon and ribavirin for 12-48 weeks.  
Open for enrollment.

Trial #2: People aged 18 to 70 who have hepatitis C virus but not HIV, and who have not taken interferon, will take
BI 201335 (an experimental HCV protease inhibitor) with peg-interferon and ribavirin for 12-48 weeks.
Closed to enrollment.